關鍵字內文
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | Harbinger ... | harbingerv... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 30.10.2023 | Foresee Pharmaceuticals to Present at the American Heart Ass... | TAIPEI, Oct. 30, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") an... | en.prnasia... |
| 25.07.2023 | Foresee Pharmaceuticals Selected for Late-Breaking Oral Pres... | TAIPEI, July 25, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") an... | en.prnasia... |
| 17.04.2023 | Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a ... | TAIPEI, April 17, 2023 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee&q... | en.prnasia... |
| 27.05.2021 | Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® f... | TAIPEI, May 27, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") annou... | en.prnasia... |
| 27.05.2021 | Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® f... | TAIPEI, May 26, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") annou... | marketscre... |
| 28.03.2021 | Foresee Pharmaceuticals Announces Dosing of First Patient in... | TAIPEIMarch 27, 2021 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee&quo... | marketscre... |
| 04.03.2021 | Foresee Pharmaceuticals Enters Exclusive License Agreement w... | TAIPEI, March 4, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") annou... | oaoa.com/n... |